Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Hannigan, Adele ^a,b   Wilson, Joanna B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b EnGeneIC Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MUTANT PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GROWTH CURVE; MOUSE; NASOPHARYNX TUMOR; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; PROTO ONCOGENE; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VIRUS; VIRUS ONCOGENE; ANIMAL; DRUG ANTAGONISM; HODGKIN DISEASE; METABOLISM; VIROLOGY;

HUMAN HERPESVIRUS 4; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; MICE; MICE, TRANSGENIC; NASOPHARYNGEAL NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 77954337080     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-184     Document Type: Article

References (21)

1. Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001, 356:461-473. 10.1098/rstb.2000.0783, 1088438, 11313005.
2. Kieff E, Rickinson AB. in Fields Virology. 2001, 2511-2573. Lippincott Williams & Wilkins, Philadelphia, Knipe DM, Howley PM, Griffin DE.
3. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990, 61:1315-1327. 10.1016/0092-8674(90)90695-B, 1694724.
4. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 1998, 95:11963-11968. 10.1073/pnas.95.20.11963, 21748, 9751773.
5. Stevenson D, Charalambous C, Wilson JB. Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGFa Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9. Cancer Res 2005, 65:8826-8835. 10.1158/0008-5472.CAN-05-0591, 16204053.
6. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003, 22:5108-5121. 10.1038/sj.onc.1206556, 12910248.
7. Miller WE, Earp HS, Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995, 69:4390-4398. 189180, 7769701.
8. Charalambous CT, Hannigan A, Tsimbouri P, McPhee GM, Wilson JB. Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF alpha prior to neoplasia. Carcinogenesis 2007, 28:1839-1848. 10.1093/carcin/bgm055, 17361012.
9. Tsai J, Lee JT, Wang W, Zhang J, Cho H, Mamo S, Bremer R, Gillette S, Kong J, Haass NK, et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA 2008, 105:3041-3046. 10.1073/pnas.0711741105, 2268581, 18287029.
10. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768. 10.1038/nrc1452, 15510157.
11. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007, 104:16164-16169. 10.1073/pnas.0702896104, 2042179, 17911266.
12. Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, Zeng YX, Zhu XF. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 2007, 6:1379-1385.
13. Curran JA, Laverty FS, Campbell D, Macdiarmid J, Wilson JB. Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res 2001, 61:6730-6738.
14. Tsimbouri P, Al-Sheikh Y, Drotar ME, Cushley W, Wilson JB. Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. J Gen Virol 2008, 89:2821-2832. 10.1099/vir.0.83296-0, 18931080.
15. Salcedo R, Fuerstenberg SM, Patarroyo M, Winberg G. The Epstein-Barr virus BNLF-1 membrane protein LMP1 induces homotypic adhesion mediated by CD11a/CD18 in a murine B-cell line, mimicking the action of phorbol ester. J Virol 1991, 65:5558-5563. 249062, 1680199.
16. Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M. Mechanism of action of a novel latent membrane protein-1 dominant negative. J Biol Chem 2001, 276:1195-1203. 10.1074/jbc.M005461200, 11031256.
17. Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996, 15:3117-3126. 450254, 8670812.
18. Macdiarmid J, Stevenson D, Campbell DH, Wilson JB. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis 2003, 24:1209-1218. 10.1093/carcin/bgg070, 12807717.
19. Diaz-Guerra M, Haddow S, Bauluz C, Jorcano JL, Cano A, Balmain A, Quintanilla M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations. Cancer Res 1992, 52:680-687.
20. Nicholls J, Hahn P, Kremmer E, Frohlich T, Arnold GJ, Sham J, Kwong D, Grasser FA. Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material. J Virol Methods 2004, 116:79-88. 10.1016/j.jviromet.2003.10.015, 14715310.
21. Mann KP, Staunton D, Thorley-Lawson DA. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol 1985, 55:710-720. 255052, 2991591.